Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

Jan. 9, 1997

Gene discovery collaboration announced

Jan. 9, 1997

ALRT announces new additions to the product pipeline

Jan. 9, 1997

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

Jan. 9, 1997

Celtrix completes phase I studies of SomatoKine

Jan. 8, 1997

Leptin triggers reproductive function

Jan. 8, 1997

Bimoclomol progresses in trials

Jan. 8, 1997

Lilly synthesizes antiobesity proteins

Jan. 8, 1997

Kissei, Servier expand licensing agreement for antidiabetic drug

Jan. 7, 1997

Amgen, Progenitor sign agreement covering leptin receptor technology

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...